Stavros Garantziotis Selected Research

inter-alpha-inhibitor

3/2019	Intravascular heavy chain-modification of hyaluronan during endotoxic shock.
1/2018	Rapid clearance of heavy chain-modified hyaluronan during resolving acute lung injury.
1/2015	The Rise and Fall of Hyaluronan in Respiratory Diseases.
11/2008	Serum inter-alpha-trypsin inhibitor and matrix hyaluronan promote angiogenesis in fibrotic lung injury.
9/2007	Inter-alpha-trypsin inhibitor attenuates complement activation and complement-induced lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stavros Garantziotis Research Topics

Disease

18	Lung Injury 11/2020 - 01/2002
16	Inflammation (Inflammations) 02/2021 - 12/2006
16	Respiratory Hypersensitivity 11/2020 - 01/2009
9	Pneumonia (Pneumonitis) 01/2020 - 01/2010
9	Asthma (Bronchial Asthma) 01/2019 - 12/2006
6	Lung Diseases (Lung Disease) 01/2020 - 10/2007
4	Fibrosis (Cirrhosis) 12/2017 - 12/2006
4	Neoplasms (Cancer) 01/2016 - 03/2011
3	Chronic Obstructive Pulmonary Disease (COPD) 02/2021 - 07/2007
3	Sepsis (Septicemia) 01/2019 - 09/2007
3	Acute Lung Injury 01/2018 - 08/2015
3	Cystic Fibrosis (Mucoviscidosis) 10/2016 - 12/2006
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2016 - 06/2014
2	Infections 11/2021 - 01/2018
2	Respiratory Insufficiency (Respiratory Failure) 02/2021 - 01/2002
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2019 - 01/2017
2	Hypersensitivity (Allergy) 11/2017 - 07/2013
2	Airway Remodeling 01/2017 - 06/2014
2	Bronchiolitis 06/2014 - 10/2007
2	Carcinogenesis 04/2014 - 11/2012
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2014 - 11/2008
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2014 - 10/2007
1	Immune System Diseases (Immune Disorders) 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Shock 03/2019
1	Endotoxemia 03/2019
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2019
1	Obesity 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2016
1	Type 2 Diabetes Mellitus (MODY) 10/2016
1	Zika Virus Infection 01/2016
1	Persistent Infection 01/2016
1	Bronchial Hyperreactivity 01/2016
1	Respiratory Syncytial Virus Infections 08/2015
1	Bronchiolitis Obliterans Syndrome 06/2014
1	Bronchitis 06/2014

Drug/Important Bio-Agent (IBA)

24	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 11/2008
11	CytokinesIBA 11/2021 - 01/2002
10	OzoneIBA 01/2020 - 04/2009
7	LipopolysaccharidesIBA 01/2020 - 07/2007
6	Proteins (Proteins, Gene)FDA Link 01/2017 - 07/2007
5	Methacholine Chloride (Methacholine)FDA Link 11/2020 - 12/2006
5	inter-alpha-inhibitorIBA 03/2019 - 09/2007
4	Carbon Nanotubes (Carbon Nanotube)IBA 12/2019 - 01/2014
3	Toll-Like Receptor 4IBA 01/2020 - 01/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2019 - 07/2007
3	Blood Proteins (Serum Proteins)IBA 03/2019 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 04/2014 - 01/2011
2	HalogensIBA 11/2020 - 01/2020
2	MetalsIBA 01/2020 - 01/2017
2	LipidsIBA 01/2020 - 01/2013
2	EnzymesIBA 03/2019 - 01/2015
2	EndotoxinsIBA 01/2019 - 12/2006
2	Complement System Proteins (Complement)IBA 01/2019 - 09/2007
2	Interleukin-17 (Interleukin 17)IBA 01/2019 - 01/2018
2	GlycosaminoglycansIBA 11/2018 - 01/2016
2	rho-Associated KinasesIBA 11/2018 - 01/2018
2	AllergensIBA 12/2017 - 11/2012
2	Interleukin-10 (Interleukin 10)IBA 08/2015 - 12/2006
2	ChlorineIBA 08/2015 - 05/2015
2	Peroxidase (Myeloperoxidase)IBA 07/2013 - 04/2012
2	Hemeproteins (Heme Protein)IBA 07/2013 - 04/2012
2	SulfitesIBA 07/2013 - 04/2012
2	mindinIBA 10/2011 - 01/2009
2	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2011 - 10/2007
2	Bleomycin (Blenoxane)FDA LinkGeneric 11/2008 - 08/2007
1	Botulinum Toxins (Botulinum Toxin)IBA 11/2021
1	cdc42 GTP-Binding ProteinIBA 11/2021
1	SmokeIBA 02/2021
1	ORALIT (ORS)IBA 01/2020
1	cholesterol 25-hydroxylaseIBA 01/2020
1	Polysaccharides (Glycans)IBA 03/2019
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2019
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2019
1	cholestenoic acidIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	AcidsIBA 01/2018
1	Environmental Pollutants (Pollutants, Environmental)IBA 12/2017
1	Bronchoconstrictor AgentsIBA 12/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2017
1	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2017
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2017
1	Interleukin-1 (Interleukin 1)IBA 01/2017
1	OxidesIBA 01/2017
1	CalciumIBA 01/2017
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Drinking WaterIBA 01/2016
1	Oxygen (Dioxygen)IBA 08/2015
1	Chemokine CCL5IBA 08/2015
1	Interleukin-13IBA 08/2015
1	naphthaleneIBA 06/2014
1	Epithelial Sodium ChannelsIBA 05/2014

Therapy/Procedure

4	Therapeutics 01/2022 - 05/2003
2	Mechanical Ventilators (Ventilator) 02/2021 - 10/2011
2	Lung Transplantation 10/2007 - 10/2007
1	Noninvasive Ventilation 02/2021
1	Anesthesia 01/2018